新浪博客

Ibrutinib.svg
IBRUTINIB By Lu imatinib
A Btk protein inhibitor.
1 - [(3 R ) -3 - [4-Amino-3-(4-phenoxyphenyl) -1 H -pyrazolo [3,4-d] PYRIMIDIN-1-yl] piperidin-1-yl] prop-2- en-1-one
1 - ((R) -3 - (4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo [3,4-d] pyrimidin-1-yl) piperidin-1-yl) prop-2-en- 1-one
CAS NUMBER 936563-96-1
Ibrutinib, PCI 32765, PCI32765, ibrutinibum, IMBRUVICA,
  • CRA-032765
  • Ibrutinib
  • Imbruvica
  • Pc-32765
  • PCI 32765
  • PCI32765
  • UNII-1X70OSD4VX

Molecular Formula: C 25 H 24 N 6 O 2
Molecular Weight: 440.49706
Company: Pharmacyclics
Approval Status: Approved February 2014 U.S. FDA : link
Treatment Area: chronic lymphocytic leukemia
Bruton's tyrosine kinase (Btk) inhibitor
U.S. Patent No: 7,514,444 , 7,718,662
Patent Validity: December 2026
read at




http://newdrugapprovals.org/2014/02/27/ibrutinib-% E4% BE% 9D% E9% B2% 81% E6% 9B% BF% E5% B0% BC /

http://newdrugapprovals.org/2014/02/27/ibrutinib-% E4% BE% 9D% E9% B2% 81% E6% 9B% BF% E5% B0% BC /

我的更多文章

下载客户端阅读体验更佳

APP专享